SCHEMBL867392

SCHEMBL867392

CC(C)(C)c1ccc2c(c1)C(=O)c1ccccc1-2

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.96
RAB9A P51151 7/20 0.96
ALDH1A1 P00352 4/20 0.96
PLA2G1B P04054 3/20 0.96
ATG4B Q9Y4P1 3/20 0.96
CASP3 P42574 2/20 0.96
SENP8 Q96LD8 2/20 0.96
SENP7 Q9BQF6 2/20 0.96
SENP6 Q9GZR1 2/20 0.96
L3MBTL1 Q9Y468 2/20 0.96
NFKB1 P19838 1/20 0.96
NFKB2 Q00653 1/20 0.96
RELA Q04206 1/20 0.96
SMN1; SMN2 Q16637 5/20 0.66
MAPK1 P28482 4/20 0.66
LMNA P02545 4/20 0.66
ATM Q13315 2/20 0.66
ELANE P08246 1/20 0.53
PARG Q86W56 2/20 0.49
MAPT P10636 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29402468 0.98 NPC1 (1.00) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL36613 0.98 NPC1 (1.00) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL13439536 0.96 NPC1 (0.89) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL15383586 0.92 NPC1 (0.81) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL29163430 0.92 NPC1 (0.81) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL13433263 0.92 NPC1 (0.88) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL5724160 0.92 NPC1 (0.88) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL2706394 0.92 ALDH1A1 (0.80) NPC1RAB9AALDH1A1PLA2G1BATG4B
SCHEMBL30552387 0.92 ALDH1A1 (0.80) NPC1RAB9AALDH1A1PLA2G1BATG4B
Dichlon SCHEMBL18227115 0.89 NPC1 (0.83) NPC1RAB9AALDH1A1PLA2G1BATG4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3238286-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2024-01-17 EP disclosed
CN-112390771-B Novel hole transport material with excellent performance and organic electroluminescent device containing same 南京高光半导体材料有限公司 2024-01-02 CN disclosed
CN-113652705-B Method for synthesizing fluorenone through catalytic electrolysis of N-hydroxyphthalimide 北京工业大学 2022-07-22 CN disclosed
CN-113652705-A Method for synthesizing fluorenone by catalyzing and electrolyzing N-hydroxyphthalimide 北京工业大学 2021-11-16 CN disclosed
US-10781183-B2 Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2020-09-22 US disclosed
US-10777750-B2 Heterocyclic spiro compounds BASF SE (DE) 2020-09-15 US disclosed
US-10665790-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2020-05-26 US disclosed
US-20190308942-A1 SMALL MOLECULE INDUCERS OF REACTIVE OXYGEN SPECIES AND INHIBITORS OF MITOCHONDRIAL ACTIVITY THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2019-10-10 US disclosed
CN-105778891-B Organic photoelectrical material, preparation method and the organic electroluminescence device including the organic material 中节能万润股份有限公司 2019-03-19 CN disclosed
US-10224492-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2019-03-05 US disclosed
US-8293715-B2 10a-Azalide compound crosslinked at 10a- and 12-positions TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-10-23 US disclosed
US-20120074336-A1 LIGHT-DRIVEN ROTARY MOLECULAR MOTORS BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE (US) 2012-03-29 US disclosed
US-20110237784-A1 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-09-29 US disclosed
US-20110166141-A1 CATHEPSIN S INHIBITORS DCB-USA, LLC (US) 2011-07-07 US disclosed
US-7964722-B2 Light-driven rotary molecular motors BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2011-06-21 US disclosed
US-7964722-B2 Light-driven rotary molecular motors BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2011-06-21 US disclosed
US-20110077394-A1 LIGHT-DRIVEN ROTARY MOLECULAR MOTORS NATIONAL SCIENCE FOUNDATION 2011-03-31 US disclosed
US-20110077394-A1 LIGHT-DRIVEN ROTARY MOLECULAR MOTORS NATIONAL SCIENCE FOUNDATION 2011-03-31 US disclosed
US-7691848-B2 Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-04-06 US disclosed
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237784-A1 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS DCLRE1A, AZI2, CHD9 NPC1 3703/4885RAB9A 58/4885ALDH1A1 2376/4885
US-20190308942-A1 SMALL MOLECULE INDUCERS OF REACTIVE OXYGEN SPECIES AND INHIBITORS OF MITOCHONDRIAL ACTIVITY SQOR, MAVS, TFAM NPC1 3235/4885RAB9A 865/4885ALDH1A1 1628/4885
US-10665790-B2 Materials for electronic devices SDHB, SDHA, ETFB NPC1 3354/4885RAB9A 2932/4885ALDH1A1 150/4885
US-20110077394-A1 LIGHT-DRIVEN ROTARY MOLECULAR MOTORS CCNA2, CCNO, SCO2 NPC1 4541/4885RAB9A 2397/4885ALDH1A1 4255/4885
US-10781183-B2 Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity SQOR, MAVS, TFAM NPC1 3235/4885RAB9A 865/4885ALDH1A1 1628/4885
US-10777750-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 NPC1 2116/4885RAB9A 1935/4885ALDH1A1 383/4885
US-20110166141-A1 CATHEPSIN S INHIBITORS CTSS, CTSV, CTSB NPC1 738/4885RAB9A 561/4885ALDH1A1 2734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.